ARTICLE | Clinical News
Immune reconstitution cell-transfer therapy: Began Phase I trial in 50 patients who will receive monthly infusions
April 4, 1994 7:00 AM UTC
Health Professionals Inc. (HPI), Fort Lauderdale, Fla. Product: Immune reconstitution cell-transfer therapy, using intravenous immune globulin and matched peripheral blood lymphocytes from an HIV-nega...